| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |